Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A2949 Linifanib (ABT-869)Target: VEGFR|PDGFRSummary: VEGFR/PDGFR inhibitor
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: IGF-1R/InsR inhibitor,potent and selective
- A1805 Imatinib Mesylate (STI571)Target: PDGFR|c-Kit|Bcr-AblSummary: Abl/c-kit/PDGFR inhibitor
- A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
- A1882 Cediranib (AZD217)Target: VEGFRSummary: VEGFR inhibitor receptor,highly potent
- A2977 Cabozantinib (XL184, BMS-907351)Summary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor
- A5092 JNJ-38877605Summary: C-Met inhibitor,ATP-competitive
- A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: HER2 inhibitor,potent and selective
- A2251 Tivozanib (AV-951)Target: VEGFRSummary: VEGFR inhibitor,potent and selective
- A2597 Brivanib (BMS-540215)Target: VEGFR|FGFR|Flk1Summary: VEGFR-2 inhibitor,ATP-competitive